Answers - Insurance

We all want to make the big annuity sale. We all want to climb to the top of our industry and get that special trip the insurance c

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ompany is offering. We all want the respect and the income we envision for ourselves.

So why is it some of us can achieve it and s

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ome of us languish in mediocrity?

Is it because we don’t work as hard as the big producers? Is it because we don’t have the magica

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

close? Is it because we don’t have the best products?

It actually is none of those things. What is it then?

It is nothing other

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

than target market accessibility. It is that simple.

Here is an example, if we only want to work with brain surgeons, how

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

likely is it we will have a full calendar every day?

What about CFOs, CEOs? Get it! The more refined our target market is the mor

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

narrow our options. So what would be a great target market?

A nationally know brokerage house recently put in guidelines for thei

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

r brokers as to who would be the basic client. In other words what was the lowest denominator for a potential client? They suggest

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ed to prospect based on income and net worth.

Their suggested guidelines were household income of $100,000 and a minimum net worth

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

f $1,000,000. I looked at this and wondered how hard it would be to find people in this category and if I could find them, could I

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

see them under a favorable basis?

If all the brokerage firms were chasing the same target market, where should I go? How do I fill

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

my calendar each day with my target market? It really was easy once I realized who would best benefit from my simple and easy to u

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

derstand products.

Here is my target market and one in which there are unlimited people to see and guess what? They don’t c

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ome with advisors in tow! I can see them for daytime appointments and they appreciate my annuity products.

My target market:
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
>

A married couple with total assets of $600,000 or LESS! This would include their home. Household income was not important and i
t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
still isn’t. I like folks in there 70’s and who would have about $200,000 in available assets. A typical case would be an IRA wit
ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust
h about $100,000 and the rest in banks and mutual funds.

This target market is everywhere and they all want someone to help them.

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
If you want to be an annuity salesman and sell $10,000,0000 a year in premium do what I do. Find nice people who are in this target
.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
market who will see you and who will appreciate your products. You will have more annuity leads and prospects than you can shake an
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip
appointment calendar at.

It is as easy as can be. Let the brokers all fight it out over their target market, use mine and get rich

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Answers - Prospect Accessibility is the Key to Annuity Leads and Sales

Related Articles: